Anthropic’s Claude Discovers New CRISPR-like Enzyme System
AI company Anthropic has announced that its Claude model autonomously identified a new CRISPR-like enzyme system in bacterial DNA, potentially opening new avenues for gene editing methods.
What happened?
On 24 September 2026, the AI company Anthropic announced that its AI model, Claude, had identified a new enzyme system within bacterial DNA. The system exhibits patterns similar to the CRISPR gene-editing tool and is described by the company as a potentially new mechanism for targeted gene editing. The discovery was made autonomously following instructions from researchers at Anthropic's biology laboratory in San Francisco.
Key facts
| AI-modell | Claude |
|---|---|
| Upptäcktstyp | CRISPR-liknande enzymsystem |
| Datum för tillkännagivande | 24 september 2026 |
| Organisation | Anthropic |
Why it matters
If the enzyme system proves functional in practice, it could provide new tools for gene therapy and biotechnological applications. This event also serves as a concrete example of how AI models can accelerate scientific discovery by identifying complex biological patterns in large datasets without prior human knowledge of those specific structures.
Who is affected?
The news primarily concerns researchers in biotechnology, genetics, and pharmaceutical development, as well as developers of AI models for scientific applications. It also affects policymakers and security experts who analyze the risks of powerful AI systems within biological research.
Impact on the EU
The discovery was made in Anthropic's San Francisco laboratory. Any future use within medicine and biotechnology in Europe will be subject to strict EU regulations concerning gene editing and medical applications, as well as the EU AI Act.
What else you should know
Anthropic's biology lab was recently established with the goal of exploring the capabilities of AI models in scientific research. The company emphasizes that the discovery was made under the supervision of researchers, highlighting the ongoing debate regarding how advanced AI should be regulated to prevent risks linked to biological security threats.
Quick answers about this story
Vad har hänt?
När hände det?
Varför spelar det roll?
Hur gjordes upptäckten?
The link opens in a new window and leads to the publisher's own site.
Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.
AI-verktyg i artikeln
Topics
Get similar news straight to your inbox
The reader's room
Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.
Sign in to submit a comment or question.
Read the article through your role
- Decide whether this affects strategy over 6–12 months or is just noise.
- Discuss with leadership: do we own the right question or does ownership need to move?
- Ask: what risk are we taking by NOT acting on this this quarter?
Generated angle — not editorial analysis of "Anthropic’s Claude Discovers New CRISPR-like Enzyme System"